FindTrial
Sign In

painless treatment of viral skin infection

A comparative study of 10% KOH solution and 5% Imiquimod for the treatment of molluscum contagiosum in the pediatric age group

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003941
Enrollment
40
Registered
2013-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- molluscum contagiosum

Interventions

Intervention1: potassium hydroxide: 10% pottasium hydroxide solution Intervention2: imiquad cream: imiquimod 5%cream application alternate nights for 12 weeks Control Intervention1: imiquimod, potassi

Sponsors

self funded
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pediatric age group presence of minimum 3 lesions patients who are willing to come for follow up

Exclusion criteria

Exclusion criteria: patients with eyelid involvemen, secondary infection, h/o hypersensitivity to imiquimod

Design outcomes

Primary

MeasureTime frame
collected data analysed by frequency, percentage, mann-whitney test and chi-squar testTimepoint: 4weeks, 8weeks, 12weeks—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactSukumar D

father muller medical college

namithachathra@yahoo.com9740203000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026